Triple
T10610067
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Lisa Matsuda |
E275981
|
entity |
| Predicate | associatedWith |
P37
|
FINISHED |
| Object | endocannabinoid system |
E275984
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: endocannabinoid system | Statement: [Lisa Matsuda, associatedWith, endocannabinoid system]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: endocannabinoid system Context triple: [Lisa Matsuda, associatedWith, endocannabinoid system]
-
A.
endocannabinoid system
chosen
The endocannabinoid system is a widespread cell-signaling network in the body that helps regulate processes such as mood, appetite, pain, memory, and immune function through cannabinoid receptors, endogenous ligands, and metabolic enzymes.
-
B.
CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
-
C.
CB2 receptor
The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
-
D.
rimonabant
Rimonabant is a selective cannabinoid CB1 receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
-
E.
CBD
CBD is a non-intoxicating compound found in cannabis that is widely used for its potential therapeutic effects, such as reducing anxiety, pain, and inflammation.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aaf948d88190806cc3a8c47a3fb2 |
completed | April 8, 2026, 7:22 p.m. |
| NER | Named-entity recognition | batch_69d6df59468881909b0c67d3f08c4b76 |
completed | April 8, 2026, 11:06 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d95ebe539881908aeff1cd65cf925f |
completed | April 10, 2026, 8:34 p.m. |
Created at: April 8, 2026, 7:32 p.m.